LONDON, May 4 /PRNewswire-FirstCall/ -- Silence Therapeutics plc, a leading European RNAi therapeutics company, today announces that the Company’s name change from SR Pharma plc has been completed. The new company name, Silence Therapeutics, and corporate identity have been put in place to better reflect the Company’s core focus on RNAi, a therapeutic approach which seeks to ‘silence’ disease relevant genes.
